Insider · CIK 0001709513
Rene Sindlev
Files at LNAI (Enochian Biosciences Inc). First filing -, latest -.
In brief
Rene Sindlev files SEC Form 4 as director and 10% owner at LNAI (Enochian Biosciences Inc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Rene Sindlev has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2024 | LNAI Enochian Biosciences Inc | AGrant or award Option to purchase shares of common stockderivativeindirect: By RS Bio ApS | +62,112 | $0.00 | $0 | 62 | Jun 27, 2024 |
| Feb 20, 2024 | LNAI Enochian Biosciences Inc | XIn-the-money exercise Common Stockindirect: By RS Bio ApS | +471,699 | $0.53 | $250k | 13,605,297 | Feb 22, 2024 |
| Feb 20, 2024 | LNAI Enochian Biosciences Inc | XIn-the-money exercise Warrant (Right to Buy)derivativeindirect: By RS Bio ApS | -471,699 | $0.00 | $0 | 471,698 | Feb 22, 2024 |
| Feb 13, 2024 | LNAI Enochian Biosciences Inc | CConversion Common Stockindirect: By RS Bio ApS | +701,260 | - | - | 13,133,598 | Feb 15, 2024 |
| Feb 13, 2024 | LNAI Enochian Biosciences Inc | CConversion Series A Convertible Preferred Stockderivativeindirect: By RS Bio ApS | -70,126 | $0.00 | $0 | 0 | Feb 15, 2024 |
| Jun 26, 2023 | LNAI Enochian Biosciences Inc | AGrant or award Common Stockindirect: By RS Bio ApS | +1,886,794 | $0.53 | $1.0M | 12,432,338 | Jun 27, 2023 |
| Jun 26, 2023 | LNAI Enochian Biosciences Inc | AGrant or award Warrant (Right to Buy)derivativeindirect: By RS Bio ApS | +943,397 | $0.00 | $0 | 943,397 | Jun 27, 2023 |
| Mar 17, 2023 | LNAI Enochian Biosciences Inc | AGrant or award Common Stockindirect: By RS Bio ApS | +877,193 | $1.14 | $1.0M | 10,545,544 | Mar 21, 2023 |
| Mar 17, 2023 | LNAI Enochian Biosciences Inc | AGrant or award Warrant (Right to Buy)derivativeindirect: By RS Bio ApS | +438,597 | $0.00 | $0 | 438,597 | Mar 21, 2023 |
| Jul 30, 2022 | LNAI Enochian Biosciences Inc | AGrant or award Option to Purchase Shares of Common Stockderivative | +32,609 | $0.00 | $0 | 32,609 | Oct 25, 2022 |
Questions about Rene Sindlev
Answered from the filings on this page, as of the latest one.
Is Rene Sindlev buying or selling?
Rene Sindlev has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Rene Sindlev's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rene Sindlev has 0.
Where does Rene Sindlev file Form 4?
Rene Sindlev has filed Form 4 at LNAI (Enochian Biosciences Inc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.